U.S. Markets
Johnson & Johnson (JNJ) expands US footprint with more than USD 1bln investment in next generation cell therapy manufacturing facility in Pennsylvania
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
